SGAustria looks forward to full commercialization of Cell-in-a-Box® driven by changes in PharmaCyte Board of Directors

… PharmaCyte Biotech, Inc. (NASDAQ:PMCB) SINGAPORE, October 10, 2022 /⁨ … becoming a vibrant, productive biotechnology company with a clear strategic … operations in Singapore and Thailand. SGAustria performs biopharmaceutical and technology development …